Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alireza Atri

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
Behavioral Neuroscience|February 26, 2004
Blockade of central cholinergic receptors impairs new learning and increases proactive interference in a word paired-associate memory taskAlireza Atri, Seth Sherman, Kenneth A Norman, et al.
Neurology|June 25, 2026
Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson DiseaseCharles H Adler, Chelva Janarthanam, Geidy E Serrano, et al.
Archives of Neurology|May 11, 2011
Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trialsAlireza Atri, Jacqueline L O'Brien, Aishwarya Sreenivasan, et al.
Neurodegenerative Disease Management|May 20, 2026
Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer's diseaseJeffrey L Cummings, Alireza Atri, Mary Sano, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Post-Acute COVID-19 Effects on Diagnostic Conversion Rates And Standardized Cognitive and Motor Test Scores in a Longitudinal Study of Independent, Community-Recruited Elderly SubjectsNathaniel Dunckley, Nan Zhang, Charles H Adler, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 6, 2022
Effect of masupirdine (SUVN-502) on cognition in patients with moderate Alzheimer's disease: A randomized, double-blind, phase 2, proof-of-concept studyRamakrishna Nirogi, John Ieni, Vinod Kumar Goyal, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 22, 2020
FLAME: A computerized neuropsychological composite for trials in early dementiaHelen Brooker, Gareth Williams, Adam Hampshire, et al.
Neuro-Degenerative Diseases|March 30, 2012
Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's diseaseDonald G McLaren, Aishwarya Sreenivasan, Eli L Diamond, et al.
Journal of Alzheimer'S Disease : JAD|March 14, 2025
Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodiesCecilia Tremblay, Neha Shakir, Nan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 8, 2023
Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohortParichita Choudhury, Nan Zhang, Charles H Adler, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Behavioral Neuroscience|February 26, 2004
Blockade of central cholinergic receptors impairs new learning and increases proactive interference in a word paired-associate memory taskAlireza Atri, Seth Sherman, Kenneth A Norman, et al.
Neurology|June 25, 2026
Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson DiseaseCharles H Adler, Chelva Janarthanam, Geidy E Serrano, et al.
Archives of Neurology|May 11, 2011
Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trialsAlireza Atri, Jacqueline L O'Brien, Aishwarya Sreenivasan, et al.
Neurodegenerative Disease Management|May 20, 2026
Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer's diseaseJeffrey L Cummings, Alireza Atri, Mary Sano, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Post-Acute COVID-19 Effects on Diagnostic Conversion Rates And Standardized Cognitive and Motor Test Scores in a Longitudinal Study of Independent, Community-Recruited Elderly SubjectsNathaniel Dunckley, Nan Zhang, Charles H Adler, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 6, 2022
Effect of masupirdine (SUVN-502) on cognition in patients with moderate Alzheimer's disease: A randomized, double-blind, phase 2, proof-of-concept studyRamakrishna Nirogi, John Ieni, Vinod Kumar Goyal, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 22, 2020
FLAME: A computerized neuropsychological composite for trials in early dementiaHelen Brooker, Gareth Williams, Adam Hampshire, et al.
Neuro-Degenerative Diseases|March 30, 2012
Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's diseaseDonald G McLaren, Aishwarya Sreenivasan, Eli L Diamond, et al.
Journal of Alzheimer'S Disease : JAD|March 14, 2025
Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodiesCecilia Tremblay, Neha Shakir, Nan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 8, 2023
Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohortParichita Choudhury, Nan Zhang, Charles H Adler, et al.
Pageof 15